JENNIFER STOCKWELL: Open Payments
NPI 1881383636 · HENDERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 26 payments from 12 companies in 2025. Trend: 2023 $535 · 2024 $2,111 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| Novo Nordisk Inc | 5 | $99 |
| Lilly USA, LLC | 3 | $57 |
| ABBVIE INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $34 |
| Corcept Therapeutics | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: CAPLYTA, MOUNJARO, VRAYLAR, NEXLETOL, NURTEC ODT, Wegovy, Korlym, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
